SURF4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.388600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.506600E-01
Normal-vs-Stage2
2.695800E-01
Normal-vs-Stage3
7.148200E-01
Normal-vs-Stage4
2.589000E-01
Stage1-vs-Stage2
9.326600E-01
Stage1-vs-Stage3
6.491600E-01
Stage1-vs-Stage4
6.870800E-01
Stage2-vs-Stage3
5.227800E-01
Stage2-vs-Stage4
7.256400E-01
Stage3-vs-Stage4
4.899600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.640600E-01
Normal-vs-AfricanAmerican
1.581210E-01
Normal-vs-Asian
2.158600E-01
Caucasian-vs-AfricanAmerican
6.997600E-01
Caucasian-vs-Asian
9.783800E-01
AfricanAmerican-vs-Asian
5.925200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.981200E-01
Normal-vs-Female
2.436000E-01
Male-vs-Female
9.374000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.806000E-01
Normal-vs-Age(41-60Yrs)
1.552820E-01
Normal-vs-Age(61-80Yrs)
4.694400E-01
Normal-vs-Age(81-100Yrs)
3.572200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.539000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.501200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.398000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.362000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.200470E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.463400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.352600E-01
Normal-vs-Daily Drinker
3.534000E-01
Normal-vs-Weekly Drinker
2.729800E-01
Normal-vs-Occasional Drinker
3.385400E-01
Normal-vs-Social Drinker
2.262000E-01
Non Drinker-vs-Daily Drinker
1.944010E-01
Non Drinker-vs-Weekly Drinker
6.248000E-02
Non Drinker-vs-Occasional Drinker
8.084200E-02
Non Drinker-vs-Social Drinker
4.050400E-02
Daily Drinker-vs-Weekly Drinker
4.847600E-01
Daily Drinker-vs-Occasional Drinker
2.994000E-01
Daily Drinker-vs-Social Drinker
1.482760E-01
Weekly Drinker-vs-Occasional Drinker
6.554200E-01
Weekly Drinker-vs-Social Drinker
4.903600E-01
Occasional Drinker-vs-Social Drinker
8.619400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.462400E-01
Normal-vs-Grade 2
9.083600E-01
Normal-vs-Grade 3
8.974000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.678400E-01
Grade 1-vs-Grade 3
2.322000E-01
Grade 1-vs-Grade 4
9.462400E-01
Grade 2-vs-Grade 3
7.247000E-01
Grade 2-vs-Grade 4
9.083600E-01
Grade 3-vs-Grade 4
8.974000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.496400E-01
Normal-vs-NonDiabetic
3.182400E-01
Diabetic-vs-NonDiabetic
2.529400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.286000E-01
Normal-vs-NoPancreatitis
3.749800E-01
Pancreatitis-vs-NoPancreatitis
5.686600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.703000E-01
Normal-vs-N1
2.935200E-01
N0-vs-N1
2.200600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.993800E-01
Normal-vs-TP53-NonMutant
3.985400E-01
TP53-Mutant-vs-TP53-NonMutant
1.722600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
